GLP Watchdog

Trimrose vs Wellorithm

Neither Trimrose nor Wellorithm has an FDA warning letter on record. On compounded tirzepatide injection, Trimrose costs $229 less a year at standing rates: $359 a month against $349 a month (billed every 4 weeks) at Wellorithm. It is one of two products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Trimrose / Wellorithm

Trimrose logo

Trimrose

6.4/10

Featured pick (affiliate partner)

Wellorithm logo

Wellorithm

7.4/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$269/moCompounded semaglutide injection
$247/moCompounded semaglutide injection, billed every 4 weeks
States
All 50 states
All 50 states and DC
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit TrimroseFull review
Visit WellorithmFull review

Wellorithm is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Trimrose pays us nothing. The scores are computed the same way for both and are shown as computed (Trimrose 6.4, Wellorithm 7.4). How we are paid

What the record shows

  1. 01

    Neither Trimrose nor Wellorithm has an FDA warning letter on record.

  2. 02

    Trimrose names seven pharmacies. Wellorithm names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Trimrose costs $229 less a year at standing rates: $359 a month against $349 a month (billed every 4 weeks) at Wellorithm. It is one of two products the two sell at comparable terms.

  4. 04

    Only Trimrose lists a price for compounded oral semaglutide. Only Wellorithm lists a price for brand-name tirzepatide pen.

  5. 05

    Trimrose does not state its cancellation terms; Wellorithm states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Trimrose

Wellorithm

Compounded semaglutide injection

$269/mo

$3,228 a year

$247/moLower

$3,211 a year, 13 charges

Compounded tirzepatide injection

$359/moLower

$4,308 a year

$349/mo

$4,537 a year, 13 charges

Brand-name semaglutide pen

$1,299/mo

$15,588 a year

$899/mo

3-month prepaid plan; not compared

Brand-name tirzepatide pen
Not sold or not priced

$1,199/mo

3-month prepaid plan; not compared

Compounded oral semaglutide

$299/mo

$3,588 a year

Not sold or not priced
Price includes
Clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Not stated
Yes, stated
Minimum term
None stated (FAQ: no long-term commitments)
None; renews every 28 days until canceled
Refunds
Not stated
Payments non-refundable once processed; 10% weight-loss guarantee can refund up to four months of fees

Read off each seller’s own pages. Trimrose: October 17, 2026. Wellorithm: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Trimrose

6.4/10
  • $229 a year less on compounded tirzepatide injection
  • Sells compounded oral semaglutide, which Wellorithm does not price
  • Names its compounding pharmacy
Visit Trimrose

The case for Wellorithm

7.4/10
Featured pick (affiliate partner)
  • $17 a year less on compounded semaglutide injection
  • Sells brand-name tirzepatide pen, which Trimrose does not price
  • States you can cancel at any time
  • Names no compounding pharmacy
Visit Wellorithm

Scores

Trimrose 6.4 · Wellorithm 7.4 out of 10. Six weighted parts.

Value25%

4.4A
vs
B
3.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
7.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

4.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Trimrose vs Wellorithm: questions

Neither Trimrose nor Wellorithm has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Trimrose names seven pharmacies. Wellorithm names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Wellorithm, by $17 a year at standing rates. Trimrose: $269 a month, about $3,228 a year. Wellorithm: $247 a month (billed every 4 weeks), about $3,211 a year.
Trimrose does not state its cancellation terms. Wellorithm states you can cancel at any time; refunds: payments non-refundable once processed; 10% weight-loss guarantee can refund up to four months of fees.
Wellorithm is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Trimrose pays us nothing. The scores are computed the same way for both and are shown as computed (Trimrose 6.4, Wellorithm 7.4).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks